| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2026-006 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于董事会秘书取得任职培训证明并正式履职的公告 上海阿拉丁生化科技股份有限公司 董事会 2026 年 2 月 3 日 公司董事会秘书联系方式如下： 联系电话：021-50560989 邮箱：aladdindmb@163.com 联系地址：上海市浦东新区新金桥路 36 号南塔 16 层 特此公告。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 上海阿拉丁生化科技股份有限公司（以下简称"公司"）于 2025 年 12 月 26 日 召开了第五届董事会第一次会议，审议通过了《关于聘任赵亚红女士为公司第五届 董事会秘书的议案》，董事会同意聘任赵亚红女士担任公司董事会秘书，任期自其 取得任职培训相关证明后正式生效，至第五届董事会届满之日止。具体内容详见公 司于 2025 年 12 月 27 日在上海证券交易所网站（w ...

Summary of Aladdin Company Conference Call Industry and Company Overview - Aladdin Company is focused on the semiconductor industry, implementing a domestic substitution strategy to increase revenue from tens of millions to over a billion in profit [2][4] - The company has achieved significant profit through acquisitions, although some acquisitions are not fully controlled, resulting in profits of over 100 million [2][4] Key Points and Arguments Domestic Market Performance - Monthly production of the company's debonding agent is currently 20 tons, with plans to expand to 50 tons by May, but demand still exceeds supply [2][3][7] - The price of the debonding agent is approximately 100,000 RMB per ton, significantly lower than the foreign price of 1,000,000 RMB per ton, addressing critical supply chain issues [2][7] Product Development and Customer Relationships - Aladdin has established strong partnerships with major domestic semiconductor clients by providing debonding agents and cleaning solutions, and is actively developing complementary products like etching solutions [2][6] - The etching solution has been validated by customers and is ready for mass production, with an expected annual demand of hundreds of tons [3][10] Financial Projections and Goals - The company aims for overseas revenue of $500-600 million in 2026, with costs exceeding $100 million, and expects to achieve profitability with a net profit margin potentially exceeding 50% [2][5] - Future revenue targets include $30 million in two to three years, with net profits reaching $50-60 million, effectively doubling the company's size [5][13] Strategic Directions - Aladdin's future strategy includes strengthening its core business, expanding into overseas markets, and seeking complementary investment opportunities [2][8] - The company plans to enhance market share through domestic substitution and improve gross margins in overseas markets [8] Pricing and Profitability Strategy - Initial product pricing was low, but as experience and demand grow, prices are expected to increase, with current gross margins nearing 90% [9] - The company is negotiating price increases with clients, which could further enhance profitability despite significant R&D investments [9] Technical Advantages - Aladdin's competitive edge lies in its technical capabilities, rapid response from R&D, and strong purification and quality control abilities [12] - The ability to adjust formulations to meet specific customer needs has helped establish long-term partnerships [12] Overseas Business Development - Aladdin began preparations for international expansion in 2018, establishing a warehouse in the U.S. in 2023 and expecting overseas sales to grow significantly [13] - The company has also invested in a large warehouse in Frankfurt and has a stake in an e-commerce platform to support future sales growth [13] Management Support for Projects - An independent team has been established to manage new projects, led by the chairman, with approximately 15-16 members dedicated to supporting development and implementation [14]

Market Performance - The recombinant protein sector declined by 0.62%, ranking among the top losers in the concept sectors, with *ST WanFang hitting the daily limit down [1] - Notable declines in the sector included Aladdin, Zexing Pharmaceutical, and Shutaishen, while 18 stocks within the sector saw price increases, with Haitai Biological, Yabao Pharmaceutical, and Zhongyuan Qihe leading with gains of 4.28%, 1.17%, and 1.08% respectively [1] Capital Flow - The recombinant protein sector experienced a net outflow of 479 million yuan, with 41 stocks seeing net outflows, and 6 stocks with outflows exceeding 30 million yuan [1] - The stock with the highest net outflow was Xilong Science, with a net outflow of 59.20 million yuan, followed by Aladdin, Shutaishen, and Aimeike with outflows of 50.46 million yuan, 39.78 million yuan, and 39.10 million yuan respectively [1] Top Gainers and Losers - The top gainers in the recombinant protein sector included Haitai Biological, with a gain of 4.28%, and the top losers included Aladdin and Shutaishen, with declines of 6.46% and 2.49% respectively [1][2] - Other notable stocks with significant capital inflows included Haitai Biological, Huayu Pharmaceutical, and Tonghua Dongbao, with net inflows of 17.77 million yuan, 15.97 million yuan, and 9.97 million yuan respectively [3]

Group 1 - The A-share market continues to show strength in the chemical sector, with notable stock increases including Hongbaoli up 9%, Jujiao Co. up 8%, and Rike Chemical up 6% [1] - The benchmark price for propylene oxide on January 21 is reported at 8233.33 yuan/ton, reflecting a 6.47% increase compared to the beginning of the month [1] - Over the past week (January 12 to 18), the price of propylene oxide has surged by 7.9%, leading the chemical market [1] Group 2 - Key stock performances include: - Hongbaoli with a market cap of 6.992 billion yuan and a year-to-date increase of 25.79% [2] - Jujiao Co. with a market cap of 4.897 billion yuan and a year-to-date increase of 27.46% [2] - Rike Chemical with a market cap of 3.598 billion yuan and a year-to-date increase of 15.87% [2] - Other notable stocks include Aladdin up 5.52%, Youcai Resources up 5.41%, and Qiaoyuan Co. up 5.23%, all showing strong year-to-date performance [2]

Group 1 - The Low Volatility Dividend Index (H30269.CSI) selects 50 securities with good liquidity, continuous dividends, moderate payout ratios, positive growth in dividends per share, high dividend yields, and low volatility, with a dividend yield of 4.49% as of January 12 [1] - The Low Volatility Dividend ETF (华夏 159547) tracks this index and has the lowest comprehensive fee rate among ETFs, with quarterly evaluations for dividends [1] - The Quality Dividend Index (931468.CSI) includes 50 listed companies that consistently pay cash dividends, have high payout ratios, and exhibit strong profitability, with a dividend yield of 3.54% as of January 12 [1] Group 2 - The Quality Dividend ETF (159758) is the only ETF tracking the Quality Dividend Index, with associated funds including Class A (016440), Class C (016441), and Class D (024263) [1] - Iwubio announced a cash dividend of 1 yuan per 10 shares (tax included), with the record date on January 19, 2026, and the ex-dividend date on January 20, 2026 [1] - Aladdin declared a cash dividend of 0.07 yuan per share (tax included), with the record date on January 16, 2026, and the ex-dividend date on January 19, 2026 [2]

Core Viewpoint - The company, Shanghai Aladdin Biochemical Technology Co., Ltd., announced an adjustment to the conversion price of its convertible bonds, "Aladdin Convertible Bonds," due to a cash dividend distribution plan for the first three quarters of 2025 [1][2]. Group 1: Dividend Distribution Plan - The company plans to distribute a cash dividend of 0.70 yuan per 10 shares (including tax) to all shareholders, without capital reserve conversion or stock bonuses [2][12]. - The total cash dividend to be distributed amounts to approximately 23.19 million yuan (including tax) based on the adjusted total share capital [12][14]. Group 2: Conversion Price Adjustment - The conversion price of the "Aladdin Convertible Bonds" will be adjusted from 13.39 yuan per share to 13.32 yuan per share due to the cash dividend distribution [3][7]. - The adjustment will take effect from January 19, 2026, and the bonds will be suspended from conversion starting January 12, 2026 [8][7]. Group 3: Calculation Methodology - The adjustment formula for the conversion price is defined as P1 = P0 - D, where P0 is the previous conversion price and D is the cash dividend per share [6][4]. - The cash dividend per share is set at 0.07 yuan, leading to the new conversion price calculation [6][11].

Group 1 - Aladdin announced a cash dividend distribution plan of 0.07 yuan per share (including tax) for the first three quarters of 2025 [1] - The record date for the dividend is set for January 16, 2026 [1] - The ex-dividend date and the dividend payment date are both scheduled for January 19, 2026 [1]

Group 1 - The company Aladdin announced a cash dividend distribution of 0.07 yuan per share (including tax) to all shareholders before the third quarter of 2025 [1] - The record date for the dividend distribution is set for January 16, 2026, with the ex-dividend date on January 19, 2026, and the payment date also on January 19, 2026 [1] - The total cash dividend to be distributed amounts to 23.1913 million yuan (including tax), calculated based on the total share capital minus the shares held in the company's repurchase account [1]

上海阿拉丁生化科技股份有限公司 关于实施 2025 年前三季度权益分派时 调整"阿拉转债"转股价格的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 因实施权益分派,本公司的相关证券停复牌情况如下： | 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2026-005 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | | 证券代码 | 证券简称 | 停复牌类型 | 停牌起始日 | 停牌期 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | | | | | | 间 | | | | 118006 | 阿拉转债 | 可转债转股复牌 | | | 2026/1/16 | 2026/1/19 | 经中国证券监督管理委员会证监许可〔2022〕72 号文同意注册，上海阿拉丁 生化科技股份有限公司（以下简称"公司"）于 2022 年 3 月 15 日向不特定对象发 行了 ...

西部证券股份有限公司 关于上海阿拉丁生化科技股份有限公司 差异化分红事项的核查意见 保荐人（主承销商） （陕西省西安市新城区东新街 319 号 8 幢 10000 室） 西部证券股份有限公司 关于上海阿拉丁生化科技股份有限公司 差异化分红事项的核查意见 三、本次差异化分红的计算依据 因公司发行可转换债券处于转股期，根据公司 2025 年第三次临时股东大会 决议通过的利润分配方案，以 2025 年 12 月 26 日（即申请日前一交易日）总股 本 332,606,976 股扣除公司回购专用账户中的股份 1,302,040 股后，本次实际参与 分配的股本数为 331,304,936 股。公司实际分派的现金红利为 0.07 元/股（含税）； 以 2025 年 12 月 26 日公司股票收盘价 12.65 元/股为参考价，按照以下公式计算 除权除息开盘参考价： 西部证券股份有限公司（以下简称"西部证券"或"保荐人"）为上海阿拉 丁生化科技股份有限公司（以下简称"阿拉丁"或"公司"）持续督导阶段的保 荐人。根据《中华人民共和国公司法》《中华人民共和国证券法》《上海证券交 易所股票上市规则》《上海证券交易所上市公司自律监 ...